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A protocol for the development of a
prediction model in mild traumatic brain
injury with CT scan abnormality: which
patients are safe for discharge?
Carl Marincowitz1* , Fiona E. Lecky2, William Townend3, Victoria Allgar4, Andrea Fabbri5 and Trevor A. Sheldon6
Abstract
Background: Head injury is an extremely common clinical presentation to hospital emergency departments (EDs).
Ninety-five percent of patients present with an initial Glasgow Coma Scale (GCS) score of 13–15, indicating a
normal or near-normal conscious level. In this group, around 7% of patients have brain injuries identified by CT
imaging but only 1% of patients have life-threatening brain injuries. It is unclear which brain injuries are clinically
significant, so all patients with brain injuries identified by CT imaging are admitted for monitoring. If risk could be
accurately determined in this group, admissions for low-risk patients could be avoided and resources could be
focused on those with greater need.
This study aims to (a) estimate the proportion of GCS13–15 patients with traumatic brain injury identified by CT
imaging admitted to hospital who clinically deteriorate and (b) develop a prognostic model highly sensitive to
clinical deterioration which could help inform discharge decision making in the ED.
Methods: A retrospective case note review of 2000 patients with an initial GCS13–15 and traumatic brain injury
identified by CT imaging (2007–2017) will be completed in two English major trauma centres. The prevalence of
clinically significant deterioration including death, neurosurgery, intubation, seizures or drop in GCS by more than 1
point will be estimated. Candidate prognostic factors have been identified in a previous systematic review.
Multivariable logistic regression will be used to derive a prognostic model, and its sensitivity and specificity to the
outcome of deterioration will be explored.
Discussion: This study will potentially derive a statistical model that predicts clinically relevant deterioration and
could be used to develop a clinical risk tool guiding the need for hospital admission in this group.
Keywords: Mild traumatic brain injury, Prognosis, Predictive model, Intra-cranial haemorrhage, Minor head injury
Background
There are 1.4 million annual attendances to emergency
departments in England and Wales following a head in-
jury [1]. Approximately 95% of patients present with an
initial score of 13–15 on the Glasgow Coma Scale (indi-
cating a normal or mildly impaired conscious level) and
are defined as having a “minor head injury”[2]. Minor
head injured patients have a 1% risk of life-threatening
traumatic brain injury (TBI) [3]. In the UK, head injury
guidelines are used to triage CT imaging in this large pa-
tient population with the aim of identifying all life-
threatening injuries [1, 4]. Adult guidelines are based on
the internationally used and validated Canadian CT
Head Rule and are applied to patients aged ≥ 16 [3, 5].
Around 7% of patients have TBI identified by CT im-
aging [6]. All of these patients are admitted to hospital
in the UK due to fears about the risk of deterioration
due primarily to intra-cranial haematoma progression,
but these risks are not well characterised (Fig. 1).* Correspondence: carl.marincowitz@hyms.ac.uk1Hull York Medical School, University of Hull, Allam Medical Building, Hull
HU6 7RX, UK
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The management of GCS13–15 patients with CT-
identified TBI is controversial with some advocating ad-
mission to higher levels of care and mandatory repeat
CT imaging due to the risk of deterioration [7]. Others
argue that some patients are at low enough risk to be
discharged safely from the ED after a short period of ob-
servation, a model of care adopted in a level 1 trauma
centre in Arizona [8]. The UK NICE guidelines (pub-
lished 2004, 2007 and 2014) state that all patients with
significant brain injuries identified by CT imaging
should be admitted to hospital, but do not qualify what
constitutes such injuries [1].
In our recent systematic review, we estimated a pooled
risk of neurosurgery in GCS13–15 patients with injuries
identified by CT imaging of 3.5% (95% C.I. 2.2–4.9%)
from the results of 36 studies [9]. A risk of clinical de-
terioration, such that patients would benefit from in-
patient hospital admission, of 11.7% (95% C.I 11.7–15.
8%) was derived from 18 studies. There was significant
variation in estimates of these outcomes across indi-
vidual studies, and no studies were conducted in the
UK where NICE guidelines are used, so relevant risk
factors were not considered. Following the introduc-
tion of the NICE guidelines, hospital admissions for
head injury increased in England [10]. It is thought
this may be due to more injuries of less clinical
significance being identified due to increased CT im-
aging of minor head injured patients [10]. Research is
required to estimate the risks of adverse outcomes in
GCS13–15 patients with injuries identified by CT im-
aging in the UK.
GCS13–15 patients with brain injuries identified by
CT imaging have a small but clinically important risk
of significant adverse outcomes. Well-conducted
prognostic research could generate models which
allow the identification of low-risk patients who could
be safely discharged from ED and high-risk patients
who would benefit from more aggressive manage-
ment. Our review identified 41 factors in 21 studies
that had been assessed as potentially affecting the risk
of adverse outcomes in this group [9]. None of this
research was conducted in the UK, and no multivari-
able models were identified that could be used to ac-
curately identify patients at sufficiently low risk of
deterioration to be discharged from the ED. Prognos-
tic research conducted within the context of NHS
care is required to assess the extent to which
GCD13–15 patients with CT-identified TBI can be
stratified by risk. This will help refine the NICE
guidelines and potentially allow better resource alloca-
tion in the management of these patients by identify-
ing those who do not require hospital admission.
Aims
1. Estimate the prevalence of clinical deterioration in
initial GCS13–15 adult patients with brain injuries
identified by CT imaging.
2. Develop a multivariable model that accurately
identifies adult patients at sufficiently low risk of
clinical deterioration that they could be discharged
from the ED.
Methods
Study design
This is a retrospective and consecutive cohort obser-
vational study. The proportion of the cohort that
clinically deteriorates will be estimated, and a multi-
variable prognostic model that predicts deterioration
will be developed. The study will be conducted and
reported in accordance with the Transparent
Reporting of a multivariable prediction model for In-
dividual Prognosis or Diagnosis (TRIPOD) recom-
mendations [11, 12].
Patients will be identified through a retrospective case
note review over a 10-year period from the end of 2007
to 2017 at Hull Royal Infirmary and Salford Royal
Hospital, two English major trauma centres.
Fig. 1 Current management of minor head injured patients
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Participants
Inclusion criteria
The inclusion criteria include patients aged ≥ 16 admit-
ted to hospital, with an initial GCS of 13 or more on
presentation to the ED and traumatic brain injury identi-
fied definitively by CT head imaging. All patients with
epidural haemorrhage, subdural haemorrhage, subarach-
noid haemorrhage, intra-cerebral haemorrhage, intra-
cerebral contusion, skull fractures and any combination
of these injuries will be considered for inclusion. All
patients with injuries identified by CT that could only be
traumatic in aetiology including skull fractures, extra-
dural haemorrhages and subdural haemorrhages will be
counted as having traumatic brain injury. Where pa-
tients have intra-cranial haemorrhage identified that
could be either traumatic or spontaneous, patients will
only be included if they have either a documented mech-
anism or evidence of head injury. This will apply to
intra-cerebral and subarachnoid haemorrhages. Included
mechanisms are falls, assault, road traffic collision, sport
and any other mechanism that could result in blunt
trauma above the clavicles. Evidence of head trauma
includes bruising, wounds or injuries above the clavi-
cles including facial and skull fractures identified
radiologically.
Exclusion criteria
Exclusion criteria include patients with obvious pene-
trating head injury or with spontaneous intra-cranial
haemorrhage. Patients will be categorised as having a
spontaneous intra-cranial haemorrhage if the haemor-
rhage could occur spontaneously or traumatically and
they have no documented preceding mechanism or
evidence of head injury or if the CT report states that
the pattern of intra-cranial haemorrhage indicates a
spontaneous event. Patients with pre-existing brain in-
juries or other pathology that makes the interpretation
of timing of injury difficult are excluded, and this
includes patients with haemorrhagic brain tumours,
chronic subdural haemorrhage or hygromas and other
types of pre-existing intra-cranial bleeds. Patients with
isolated occipital condyle fractures are excluded as these
are treated as cervical spine injuries. Patients transferred
from other EDs following identification of a brain injury
will also be excluded.
Study outcome
The outcome of interest is a composite measure of clin-
ical deterioration such that inpatient hospital admission
was warranted; this includes death due to TBI or neuro-
surgery within 30 days of attendance, ICU intervention
whilst an inpatient, seizure activity whilst an inpatient,
drop in GCS by 2 or more points whilst an inpatient or
a readmission to hospital within 30 days of injury related
to TBI.
Candidate prognostic factors
Potential candidate factors have been selected a priori by
identification of factors that individually predict deterior-
ation in the study population in our systematic review,
inclusion of additional factors that predict adverse out-
comes in prognostic models for patients with more se-
vere TBI and trauma and inclusion of factors that
represent NICE guideline standards and criteria for
treatment and investigation of head injury and TBI [1, 9,
13–15]. All factors being considered for inclusion in the
final model are presented in Table 1 with the reason for
their inclusion.
Comorbidities will be measured using a trauma-
modified Charlson Comorbidity Index. Brain injury se-
verity, as shown on CT scan, will be stratified using the
Marshall Classification, which will be calculated from
Abbreviated Injury Severity (AIS) codes for TBI using
the method described by Lesko et al. [16, 17] The Charlson
Comorbidity Index, AIS and Marshall Classification are
internationally validated prognostic scoring systems [18,
19]. Frailty will be assessed using the clinical frailty scale de-
scribed by Rockwood et al. [20].
Data collection
Screening
A database of all emergency department CT brain re-
quests and reports for patients aged 16 and over be-
tween 2007 and 2017 will be generated at the two sites
from the electronic requesting and reporting system.
This will be screened to identify potentially eligible pa-
tients with CT requests related to head injury and CT
scans with reported abnormalities related to TBI or
intra-cranial haematomas (Fig. 2). Patients identified in
this way will be matched to electronic ED case notes, re-
ports and discharge summaries to identify the subset of
patients potentially admitted with an initial GCS13–15.
Data extraction
The full case records of patients identified through screen-
ing as potentially meeting the inclusion criteria will be re-
trieved (Fig. 2). In patients who are confirmed to meet the
inclusion criteria, all a priori candidate prognostic factors
will be extracted from the case records. Demographic infor-
mation will be extracted from data recorded at the time of
presentation to the ED following head injury. Comorbidities,
frailty and pre-injury medication use will be extracted from
that recorded in the ED attendance and subsequent inpatient
hospital admission documentation. Comorbidities recorded
in the inpatient notes up to 1 year prior to the presentation
following head trauma will be included in accordance with
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the method of data collection in a recent update of the
Charlson Comorbidity Index [19].
The full inpatient records will be interrogated for evi-
dence of intervention or clinical deterioration that would
meet the composite outcome measure. Recorded patient
ED and hospital admissions after discharge following the
relevant admission for traumatic brain injury will be
assessed for evidence of deterioration, intervention or
readmission in the 30 days following the initial ED
attendance.
Patients who were included in the national Trauma
Audit and Research network (TARN) registry will be
identified locally. Using an anonymous TARN study
number, we will assess for any deaths recorded on the
TARN registry within 30 days of admission.
Research team undertaking screening and data extraction
Members of the direct emergency department care
team at each NHS trust will undertake the screening
of electronic records for patients admitted following
head injury and data extraction from case notes. Staff
undertaking data extraction will undergo data extrac-
tion training, and this includes training in abbreviated
injury scale coding of injuries on CT brain scans by
the Trauma Audit and Research Network (TARN)
which is an Association for the Advancement of
Table 1 Prognostic factors being investigated
Factors from systematic review Type of data Factors from NICE guidelines Type of data Factors from TARN TBI/trauma model Type of
data
Age Continuous 1st neurological examination
in ED
Categorical Admission Hb Continuous
Sex Categorical Equal pupils 1st examination Categorical Admission platelets Continuous
Pre-injury anti-coagulant use Categorical Both pupils reactive 1st
examination
Categorical Charlson Trauma Modified
Comorbidity Index
Continuous
Pre-injury anti-platelet use Categorical SIGN of skull fracture 1st
examination
Categorical Admission BM Continuous
GCS on arrival to ED Categorical Seizures in ED Categorical Frailty score Continuous
BP on arrival ED Continuous Vomiting in ED Categorical
HAIS Continuous An occupant ejected from
a motor vehicle
Categorical
Marshall Classification Categorical Mechanism of injury Categorical
Single injury Categorical Amnesia Categorical
Comment on midline shift Categorical Intoxicated EToH time of injury Categorical
Comment on size of bleed Seizures before arrival ED Categorical
Additional injuries Categorical Vomiting before arrival ED Categorical
Sats on arrival ED Continuous A pedestrian or cyclist struck
by a motor vehicle
Categorical
A fall from height of > 1 m or 5
stairs
Categorical
Fig. 2 Population screening and selection
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Automotive Medicine-accredited trainer to ensure the
use of AIS dictionary in a reliable and reproducible
fashion. Data extraction will be piloted over a 1-
month period. Hypothetical and non-identifiable
training samples of potential patient records will be
generated at both sites during the training period and
will be used to check the quality of, and validate, data
extraction in the research team. The research team
will not be blinded to outcomes. However, most prog-
nostic variables being collected are demographic and
other factors not subject to interpretation. Patients
are also not being allocated to treatment groups, and
therefore, data collection is less likely to be biased in
favour of a specific outcome.
Sample size
Sample size of a prognostic study is informed by three
factors: anticipated prevalence of the outcome (in this
study clinical deterioration), desired sensitivity of the
model to the outcome and the precision of the 95% con-
fidence interval around the sensitivity of the model [12].
We have based our sample size on a 10% estimated
prevalence of clinical deterioration in our systematic
review and our desired precision of the sensitivity of
the derived model for this outcome [9]. Research into
discharge decision making in patients presenting to
the ED with chest pain indicated that a 1/100 risk of
a patient being discharged who subsequently had a
significant cardiac event may be an acceptable risk
threshold to both patients and clinicians [21]. There-
fore, we will aim for 99% sensitivity for clinical de-
terioration as this may correspond to a clinically
acceptable level of model accuracy.
A sample size of approximately 2000 patients is re-
quired, based upon the desired 99% sensitivity in
order that the maximum marginal error of the esti-
mate does not exceed 1.4% with a 95% confidence
interval [22]. Based upon previous data collection, we
estimate at least 100 patients will be eligible for in-
clusion per year at each site of data collection over
the 10-year period of interest [23].
Statistical analysis
Outcome estimate
The proportion of patients that fulfil the composite
measure of deterioration will be estimated. A sample
size of 2000 patients will allow us to estimate the preva-
lence of clinically significant deterioration with a 1.3%
margin of error at a 95% confidence level.
Model development
Multivariable logistic regression with backward stepwise se-
lection will be used to find the best combinations of candi-
date factors highly sensitive for detecting deterioration while
achieving the maximum possible specificity. This approach is
favoured as all correlations between predictors are consid-
ered in the modelling procedure and there is easier transpar-
ency of reporting [12].
Candidate prognostic factors with a P value greater
than 0.05 will be selected for removal. Forced variables
(predictors) that we consider as having clinical relevance,
as indicated in our systematic review and the NICE
guidelines, will initially also be considered for inclusion
in our model and retained in the initial steps of back-
wards elimination. In the final model, all factors that do
meet the significance level will be removed.
The sample size of 2000, with an anticipated prevalence
of clinical deterioration of around 10%, will allow the
model to include 20 variables, based on the rule of at least
10 outcome events per parameter estimated.
Continuous factors will not be categorised initially to avoid
a loss of power [24, 25]. Calibration (the agreement between
outcome predictions from the model and the observed out-
comes) will be tested with the Hosmer–Lemeshow test. We
will assess the apparent performance of the fitted models for
discrimination using the C-statistic (equal to the area under
the receiver operating characteristic curve) and the sensitivity
for clinically significant deterioration [26].
Internal validation using the bootstrap validation ap-
proach will be undertaken to evaluate the performance
and optimism of the developed model [27]. This will
allow the use of the complete data set for model devel-
opment and provide a mechanism to account for model
overfitting or uncertainty in the model development
process. We will quantify any optimism in the final pre-
diction model and estimate a so-called shrinkage factor
that can be used to adjust the regression coefficients and
apparent performance for optimism. This will lead to a
new final model being produced in each of the bootstrap
samples. We will average the difference in the perform-
ance of the models to obtain a single estimate of opti-
mism for the C-statistic.
Missing data
As data are to be extracted from clinical records,
missing variable data will inevitably occur. Although
it is possible to verify the data to judge whether miss-
ing data are missing completely at random (MAR) or
associated with observed variables, it is generally im-
possible to prove that data are indeed MAR or
whether they are not missing at random (MNAR)
[24]. Multiple imputation will be used to impute
missing data with the number of imputations deter-
mined by the amount of missing data, under a miss-
ing random assumption, so as to avoid excluding
patients from the analysis. This will be completed
using STATA with the exact method determined by
the amount, type and distribution of the missing data,
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and we will adhere to recognised guidelines for ap-
propriate use and reporting of methods to deal with
missing data [28, 29]. After imputation, a sensitivity
analysis will be undertaken to determine how the
substantive results depend on the multiple imputation
method employed. This is consistent with the TRI-
POD recommendations with the handling of missing
data in prognostic studies [12].
Model accuracy
The sensitivity and specificity of the model for detecting
patients at low risk of deterioration will be calculated
comparing the classification of each patient by the
model with whether they actually deteriorated. To assess
how informative lack of deterioration is, the model will
be derived again for those patients who do not deterior-
ate within 24 h. We will determine whether a more ac-
curate model can be produced for those still in hospital
after 24 h.
A receiver operating characteristic (ROC) curve for
both models will be plotted and the trade-off between
the sensitivity and specificity of the model explored [30].
As indicated previously, a 1/100 risk of deterioration fol-
lowing discharge may be clinically acceptable, and there-
fore, our model will aim for at least a 99% sensitivity to
deterioration [21].
Sensitivity analysis
The 10-year period of data collection represents a long
time period over which clinical practice and outcomes
may have changed. To assess for this, we will estimate
the yearly prevalence of clinical deterioration and note
any statistically significant changes in outcome over
time. In addition, because NICE guidelines were updated
in 2014 (with minor changes to the indications for CT
brain imaging), the prognostic model will be estimated
solely for the time period 2014–2017 and compared to
the model estimated for the whole time period [1].
Exploratory analysis
Individual patient data from a prospective Italian cohort
study is available to the research team [31]. The vari-
ables collected in the Italian study and how they com-
pare to the variables being collected in our study are
shown in Table 2. If most factors present in the multi-
variable model developed in our study are present in the
Italian data set, then we will assess the effect of these
factors on the risk of deterioration in a multivariable
model derived in the Italian data set. If the effect esti-
mates are similar to those estimated in the data collected
in England, then we will combine the individual patient
data of the two data sets to improve the precision of the
model estimates.
Discussion
Strengths
To the authors’ knowledge, this will be the largest cohort
study conducted that assesses clinical deterioration in
GCS13–15 patients with brain injuries identified by CT
imaging. We are collecting data from multiple sites and
potentially incorporating data from a different European
country. The definition of clinical deterioration is wide
and defined to encompass potential benefits of hospital
admission from the ED. This outcome is one that can be
used to help inform clinical decision making regarding
the selection of patients in this group that would benefit
from hospital admission.
Limitations
Data collection is retrospective and will be limited by
the nature and accuracy of the data clinically recorded.
However, such data are likely to be applicable and imple-
mentable in current routine practice. Given the large
sample size required for this study and the challenges of
prospectively recruiting patients in the ED, a retrospect-
ive method for data collection represents a feasible and
pragmatic data collection strategy.
Table 2 Comparison between Italian data set and data being
collected
Factor In Italian
data
Factor In Italian
data
Age Yes Equal pupils 1st
examination
Yes
Sex Yes Both pupils reactive
1st examination
Yes
Pre-injury anti-coagulant
use
Yes SIGN of skull fracture
1st examination
No
Pre-injury anti-platelet use No Seizures in ED No
Charlson Trauma Modified
Comorbidity Index
Yes Vomiting in ED No
A pedestrian or cyclist
struck by a motor vehicle
Yes HAIS No
An occupant ejected from
a motor vehicle
Yes Marshall Classification Yes
A fall from height of
> 1 m or 5 stairs
Yes Single injury and type
of injury
Yes
Mechanism of injury No Comment on midline
shift
No
Amnesia Yes Comment on size of
bleed
No
Loss of consciousness Yes Frailty score No
Intoxicated time of
injury
No Admission Hb No
Seizures before arrival ED Yes Admission platelets No
Vomiting before arrival ED Yes Admission BM No
GCS on arrival to ED Yes Additional injuries Yes
BP on arrival ED No
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Outcomes will only be assessed during hospital admis-
sion and re-attendances to the hospitals where data
collection is occuring. This may underestimate deterior-
ation following discharge especially if patients die in the
community or deteriorate and are readmitted to a differ-
ent hospital. We will estimate the effect of this possible
bias by conducting a sensitivity analysis using data for
the subset of patients registered on the Trauma and
Audit Network Database where complete data following
discharge is available.
Further research
Prognostic models tend to perform optimistically
using the data from which they were derived, and
therefore, their accuracy requires external validation
in separate data sets [12]. There are different strat-
egies for this and we will attempt to validate the
model derived from this study in a sub-population of
a European prospective cohort of TBI patients that is
currently ongoing (CENTER-TBI), with data expected
to be available in 2018 [32, 33]. Our validation study will
be subject to a separate protocol. If the model appears suf-
ficiently accurate at identifying low-risk TBI, that patients
could be safely discharged, implementation will be tested
prospectively in the context of the NHS.
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